Increasing worldwide adoption of GLP-1 therapies has accelerated investments in high-capacity peptide synthesis, purification, and commercial production infrastructure, making commercial manufacturing the largest revenue-generating segment within the market
For example, one of the studies referenced above breaks down how each drug performed in terms of nausea, diarrhea, and vomiting:2 As you can see, these arent night-and-day differences, but if you already have a sensitive stomach, it might be smarter to start with semaglutide to give yourself the best chance of mitigating digestive symptoms
Ahn JH, Shin MS, Jun MA, Jung SH, Kang SK, Kim KR, et al
& You, M
It mimics the action of glucagon-like peptide-1 (GLP-1), stimulating insulin release, suppressing glucagon secretion, and slowing gastric emptying